31 results
8-K/A
EX-99.1
RNAC
Cartesian Therapeutics Inc
23 Jan 24
Independent Auditor’s Report
4:05pm
(Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). ASU 2020-06 simplifies the accounting for certain
8-K
EX-10.2
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
the writing or settlement of options or other hedging transactions, whether such options are listed on an options exchange or otherwise;
a combination of any … in compliance with FINRA IM-2121.01.
In connection with sales of the Shares or otherwise, the selling stockholders may enter into hedging transactions
DEFR14A
ctkvoiwitsbb4eei6p
3 May 22
Revised proxy
2:15pm
PRE 14A
xdvwz stq
22 Apr 22
Preliminary proxy
3:08pm
424B5
wo0q 7hig
6 Apr 22
Prospectus supplement for primary offering
9:45pm